Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system

Abstract

Poly lactic acid is a biodegradable, biocompatible, and non-toxic polymer, widely used in many pharmaceutical preparations such as controlled release formulations, parenteral preparations, surgical treatment applications, and tissue engineering. In this study, we prepared lipid-polymer hybrid nanoparticles for topical and site targeting delivery of Norfloxacin by emulsification solvent evaporation method (ESE). The design of experiment (DOE) was done by using software to optimize the result, and then a surface plot was generated to compare with the practical results. The surface morphology, particle size, zeta potential and composition of the lipid-polymer hybrid nanoparticles were characterized by SEM, TEM, AFM, and FTIR. The thermal behavior of the lipid-polymer hybrid nanoparticles was characterized by DSC and TGA. The prepared lipid-polymer hybrid nanoparticles of Norfloxacin exhibited an average particle size from 178.6 ± 3.7 nm to 220.8 ± 2.3 nm, and showed very narrow distribution with polydispersity index ranging from 0.206 ± 0.36 to 0.383 ± 0.66. The surface charge on the lipid-polymer hybrid nanoparticles were confirmed by zeta potential, showed the value from +23.4 ± 1.5 mV to +41.5 ± 3.4 mV. An Antimicrobial study was done against Staphylococcus aureus and Pseudomonas aeruginosa, and the lipid-polymer hybrid nanoparticles showed potential activity against these two. Lipid-polymer hybrid nanoparticles of Norfloxacin showed the %cumulative drug release of 89.72% in 24 h. A stability study of the optimized formulation showed the suitable condition for the storage of lipid-polymer hybrid nanoparticles was at 4 ± 2 °C/60 ± 5% RH. These results illustrated high potential of lipid-polymer hybrid nanoparticles Norfloxacin for usage as a topical antibiotic drug carriers.

Download
Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system
Vivek Davea, , , Renu Bala Yadava, Kriti Kushwahaa, Sachdev Yadava, Swapnil Sharmaa, Udita Agrawalb
a Department of Pharmacy, Banasthali University, Banasthali, Rajasthan, India
b Sagar Institute of Research and Technology-Pharmacy, Bhopal, 462041, India
https://doi.org/10.1016/j.bioactmat.2017.07.002
1-s2.0-S2452199X17300403-main.pdf
Adobe Acrobat Document 2.7 MB
Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system
Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system